The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. "Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies"

Mol Psychiatry. 2023 Aug;28(8):3164-3166. doi: 10.1038/s41380-023-02102-2. Epub 2023 May 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Discovery
  • Hallucinogens*
  • Ketamine* / pharmacology
  • Ketamine* / therapeutic use
  • Proteomics
  • Psychiatry*

Substances

  • Hallucinogens
  • Ketamine